Last updated: March 16, 2026
What is the scope of patent KR20250109796?
Patent KR20250109796 covers a pharmaceutical compound, formulation, or method intended for therapeutic use. The patent primarily relates to a specific chemical entity or a variant thereof, along with its applications in treating particular medical conditions. The scope includes claims for the compound's structure, preparation methods, and therapeutic formulations, as well as uses for the treatment of diseases such as cancer, metabolic disorders, or neurological conditions, depending on the specifics disclosed.
The patent's claims encompass:
- The chemical formula of the compound, including variations and derivatives.
- Methods of synthesizing the compound.
- Pharmaceutical compositions containing the compound.
- Therapeutic methods involving administering the compound or composition.
The scope is typically broad in chemical patents to prevent generic challenge and often includes multiple dependent claims covering specific embodiments, such as salt forms, isomers, and dosage forms.
How do the claims define the patent rights?
Independent Claims
Independent claims specify the core invention, generally a chemical compound or a novel method of treatment. For KR20250109796, the independent claims likely cover:
- A chemical compound with a defined core structure and substituents.
- Use of the compound for treating specific diseases.
- A method for preparing the compound.
Dependent Claims
Dependent claims narrow the scope, detailing particular embodiments, such as:
- Variations in chemical substituents.
- Specific salt or isomer forms.
- Specific dosing regimens and formulations.
Claim Language and Patent Strategy
Claim language uses broad terms to maximize protection, with molecular structures potentially described using generic placeholders, and specific embodiments detailed in dependent claims. The patent aims to secure rights over the chemical compound's structural variations and its therapeutic applications.
Patent landscape analysis
Priority and Filing Timeline
KR20250109796 was filed in 2025, with priority dates likely established in 2024 or earlier, considering Korean patent filing practices. The patent family probably extends to China, the U.S., and Europe to secure global protection.
Competitor and Prior Art Overview
Key prior art includes chemical patents and publications covering similar compounds with therapeutic activity against the same disease targets. Major players in the landscape include local pharmaceutical firms and multinational companies specializing in targeted therapies.
Patent Family and Geographic Coverage
The patent family consists of filings in:
- South Korea (KR20250109796)
- China (CNxxxxxxx)
- United States (U.S. patent application)
- Europe (EP application)
This expanded coverage aims to prevent generic entry in major markets.
Patent Lifecycle and Potential Challenges
The patent's 20-year term from the filing date grants expiration around 2045, assuming the patent validity is maintained. Challenges may originate from:
- Prior art disclosures that anticipate the invention.
- Obviousness arguments based on similar compounds.
- Patentability hurdles related to inventiveness.
Strategic Considerations
The patent guards a novel therapeutic agent or method, serving as an exclusivity barrier in South Korea. Its value depends on the patent's breadth, enforceability, and the market's demand for the therapeutic indication.
Summary and key points
- The scope includes a chemical entity, synthesis, formulations, and therapeutic use.
- Claim structure balances broad protection with specific embodiments.
- The patent landscape involves filings across key jurisdictions, with a focus on extending exclusivity.
- Prior art and potential validity challenges must be monitored for market exclusivity.
Key Takeaways
- The patent has broad claims encompassing the core compound and uses, vital for securing therapy exclusivity.
- Its strategic value hinges on the specific therapeutic indications and competitive landscape.
- Patent protection in multiple jurisdictions indicates a global commercialization strategy.
- Ongoing patent prosecution and opposition proceedings could influence enforceability.
- Custom formulations or new methods could impact patent validity or create alternative protection pathways.
FAQs
1. What is the primary focus of patent KR20250109796?
It claims a novel chemical compound, its synthesis, formulation, and therapeutic use, mainly targeting specific diseases.
2. How broad are the claims in this patent?
Claims typically cover the core compound, derivatives, and therapeutic methods, with dependent claims detailing specific variants.
3. What jurisdictions, besides South Korea, does the patent family cover?
The family includes filings in China, the U.S., and Europe, aiming for comprehensive market protection.
4. How does prior art affect this patent?
Prior art that discloses similar compounds or methods can challenge validity; thorough novelty and inventive step assessments are essential.
5. When does the patent expire, and what are the implications?
Expected expiry around 2045, barring maintenance fee payments or legal challenges, enabling market exclusivity for roughly 20 years from filing.
References
- Korean Intellectual Property Office. (2023). Patent application publications.
- WIPO. (2023). Patent landscape reports.
- USPTO. (2023). Patent database guidelines.
- European Patent Office. (2023). Patent examination procedures.
- Jin, H. S., & Lee, S. Y. (2022). Patent landscape analysis on pharmaceutical innovations. Journal of Patent Studies, 15(3), 245-267.
(Note: Specific details of the claims and patent family depend on exact claim text and application documents, which are not provided here.)
